Projects per year
Personal profile
Research interests
- COVID-19
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Slobodan Paessler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
D-glucose or D-mannose analogs related to 2-deoxy-D-glucose in glioma and glioma stem cells
9/1/21 → 8/31/22
Project: Other project
-
-
Evaluation of Sorrento Therapeutics' Natural Killer Cells for COVID-19 Treatment
3/11/20 → 3/1/23
Project: Other project
-
Creation of antiviral drugs: In vivo efficacy of the compound against Lassa virus
12/1/19 → 3/31/23
Project: Other project
-
Creation of antiviral drugs: In vivo efficacy of the compound against Lassa virus
12/1/19 → 3/31/23
Project: Other project
-
CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model
Maruyama, J., Reyna, R. A., Kishimoto-Urata, M., Urata, S., Manning, J. T., Harsell, N., Cook, R., Huang, C., Nikolich-Zugich, J., Makishima, T. & Paessler, S., May 2022, In: PLoS pathogens. 18, 5, e1010557.Research output: Contribution to journal › Article › peer-review
Open Access -
Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 antiapoptotic cellular program
Byerly, C. D., Mitra, S., Patterson, L. N. L., Pittner, N. A., Velayutham, T-S., Paessler, S., Veljkovic, V. & McBride, J. W., May 2022, In: PLoS pathogens. 18, 5, e1010345.Research output: Contribution to journal › Article › peer-review
Open Access -
Ehrlichia SLiM Ligand Mimetic Activates Notch Signaling in Human Monocytes
Patterson, L. N. L., Velayutham, T. S., Byerly, C. D., Bui, D. C., Patel, J., Veljkovic, V., Paessler, S. & McBride, J. W., Apr 2022, In: mBio. 13, 2Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach**
Sencanski, M., Perovic, V., Milicevic, J., Todorovic, T., Prodanovic, R., Veljkovic, V., Paessler, S. & Glisic, S., Feb 2022, In: ChemistryOpen. 11, 2, e202100248.Research output: Contribution to journal › Article › peer-review
Open Access -
Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever
Mantlo, E. K., Maruyama, J., Manning, J. T., Wanninger, T. G., Huang, C., Smith, J. N., Patterson, M., Paessler, S. & Koma, T., Apr 2022, In: Journal of virology. 96, 8Research output: Contribution to journal › Article › peer-review
Activities
- 1 Types of External academic engagement - Membership of peer review panel or committee
-
Virology B Study Section, Center for Scientific Review
Slobodan Paessler (Member)
Jul 1 2015 → Jun 30 2021Activity: Other activity types › Types of External academic engagement - Membership of peer review panel or committee
Press / Media
-
Sorrento Therapeutics And ViralClear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
Cheng Huang, John Manning & Slobodan Paessler
9/30/20
19 items of Media coverage
Press/Media: Expert Comment
-
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19
Cheng Huang, John Manning & Slobodan Paessler
9/30/20
21 items of Media coverage
Press/Media: Expert Comment
-
ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution
Cheng Huang, John Manning & Slobodan Paessler
9/22/20
12 items of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies Adopts Stockholder Rights Agreement
Cheng Huang, John Manning & Slobodan Paessler
7/16/20 → 7/19/20
2 items of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit Nasdaq:BSGM
Cheng Huang, John Manning & Slobodan Paessler
7/17/20 → 7/18/20
27 items of Media coverage
Press/Media: Expert Comment